Philip Grant

Philip Grant is a Clinical Associate Professor in the Department of Medicine - Infectious Diseases at Stanford University School of Medicine. His research focuses on antiretroviral therapy, HIV complications (e.g., immune reconstitution inflammatory disease, osteoporosis), and infectious disease pathogenesis. He completed his medical degree at UCSF (2000), residency at University of Washington (2003), and an infectious diseases fellowship at Stanford (2010). Board-certified in Infectious Disease since 2008, he leads clinical efforts at Stanford Health Care's Division of Infectious Diseases.

Research interests include cytokine dynamics in aging populations, sex-based immunological differences in Long Covid, and antiretroviral resistance mechanisms. Key contributions involve HCV treatment trials in Rwanda, demonstrating sofosbuvir-based regimens' efficacy for genotype 4 infections, and analyzing public health infrastructure's impact on pandemic outcomes.

Recent work includes groundbreaking studies linking cytokine surges to preclinical cancer detection and identifying immune correlates of persistent post-COVID symptoms. He co-authored over 69 publications, with notable contributions to PNAS, Science Translational Medicine, and LANCET Gastroenterology.

• Grants: NIH-funded studies on HIV resilience, cytokine biomarkers
• Labs/Teams: Collaborates with Stanford's HIV Immunopathogenesis Group and Global Health Trials Unit